Restenosis risk factors after coronary stenting in metabolic syndrome patients
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus. Recently, MS has also been regarded as a pathology enhancing coronary restenosis risk. Certain...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1207 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041476965203968 |
|---|---|
| author | N. M. Danilov T. T. Gorgadze A. P. Savchenko I. E. Chazova |
| author_facet | N. M. Danilov T. T. Gorgadze A. P. Savchenko I. E. Chazova |
| author_sort | N. M. Danilov |
| collection | DOAJ |
| description | This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus. Recently, MS has also been regarded as a pathology enhancing coronary restenosis risk. Certain MS features (reduced NO release after oral glucose tolerance test; increased leptin level; hyperinsulinemia, insulin resistance) are important predictors of intra-stent restenosis in coronary heart disease (CHD) patients with normal fasting levels of glucose and glycated hemoglobin. In CHD and MS patients, new, antiproliferative drug-coated stent use could be recommended. |
| format | Article |
| id | doaj-art-ecdbddbd7ed448818baa9a6833bd41c7 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2007-04-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-ecdbddbd7ed448818baa9a6833bd41c72025-08-20T02:55:46Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-04-01627174919Restenosis risk factors after coronary stenting in metabolic syndrome patientsN. M. Danilov0T. T. Gorgadze1A. P. Savchenko2I. E. Chazova3A.L. Myasnikov Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development, MoscowA.L. Myasnikov Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development, MoscowA.L. Myasnikov Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development, MoscowA.L. Myasnikov Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, State Federal Agency for Health and Social Development, MoscowThis review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus. Recently, MS has also been regarded as a pathology enhancing coronary restenosis risk. Certain MS features (reduced NO release after oral glucose tolerance test; increased leptin level; hyperinsulinemia, insulin resistance) are important predictors of intra-stent restenosis in coronary heart disease (CHD) patients with normal fasting levels of glucose and glycated hemoglobin. In CHD and MS patients, new, antiproliferative drug-coated stent use could be recommended.https://cardiovascular.elpub.ru/jour/article/view/1207coronary stentingmetabolic syndromecoated stentsrisk factorsrestenosis |
| spellingShingle | N. M. Danilov T. T. Gorgadze A. P. Savchenko I. E. Chazova Restenosis risk factors after coronary stenting in metabolic syndrome patients Кардиоваскулярная терапия и профилактика coronary stenting metabolic syndrome coated stents risk factors restenosis |
| title | Restenosis risk factors after coronary stenting in metabolic syndrome patients |
| title_full | Restenosis risk factors after coronary stenting in metabolic syndrome patients |
| title_fullStr | Restenosis risk factors after coronary stenting in metabolic syndrome patients |
| title_full_unstemmed | Restenosis risk factors after coronary stenting in metabolic syndrome patients |
| title_short | Restenosis risk factors after coronary stenting in metabolic syndrome patients |
| title_sort | restenosis risk factors after coronary stenting in metabolic syndrome patients |
| topic | coronary stenting metabolic syndrome coated stents risk factors restenosis |
| url | https://cardiovascular.elpub.ru/jour/article/view/1207 |
| work_keys_str_mv | AT nmdanilov restenosisriskfactorsaftercoronarystentinginmetabolicsyndromepatients AT ttgorgadze restenosisriskfactorsaftercoronarystentinginmetabolicsyndromepatients AT apsavchenko restenosisriskfactorsaftercoronarystentinginmetabolicsyndromepatients AT iechazova restenosisriskfactorsaftercoronarystentinginmetabolicsyndromepatients |